The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
India’s efforts are aimed at boosting health at the last mile
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
These initiatives aim to improve access to healthcare for rare disease patients
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated
